Chemoinformaics analysis of (1S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one
| Molecular Weight | 152.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
| Exact Molecular Weight | 152.12 | nRing | 2 |
| Solubility: LogS | -2.294 | nHRing | 0 |
| Solubility: LogP | 2.324 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 16.9193 |
| QED | 0.521 |
| Synth | 4.12 |
| Natural Product Likeliness | 2.073 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.582 |
| MDCK | 0.0000222 |
| BBB | 0.832 |
| PPB | 0.792154 |
| VDSS | 0.842 |
| FU | 0.378267 |
| CYP1A2-inh | 0.078 |
| CYP1A2-sub | 0.76 |
| CYP2c19-inh | 0.286 |
| CYP2c19-sub | 0.94 |
| CYP2c9-inh | 0.117 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.629 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.397 |
| CL | 13.808 |
| T12 | 0.701 |
| hERG | 0.005 |
| Ames | 0.025 |
| ROA | 0.189 |
| SkinSen | 0.051 |
| Carcinogencity | 0.425 |
| EI | 0.981 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.032 |
| Antiviral | No |
| Prediction | 0.927052 |